In:
City Healthcare, Research Institute for Healthcare Organization and Medical Management, Vol. 4, No. 2 ( 2023-06-19), p. 30-40
Abstract:
Russia and other countries report an increase in the incidence of malignant neoplasms, and approximately 10 % of all oncological cases have hereditary background. Molecular genetic testing in patients with diagnosed malignant neoplasms and a suspected hereditary factor will help to select effective modern methods of treatment and prevention of the development of neoplasms of other localizations. According to the study, 12,6 % of patients had hereditary cancer syndrome, which allowed to administer molecular genetic tests to patients’ relatives. Consequently, it becomes possible to detect hereditary cancer risk factors, improve the efficiency of clinical examination, elaborate and implement programs for prevention and early detection of the disease.
Type of Medium:
Online Resource
ISSN:
2713-2617
DOI:
10.47619/2713-2617.zm.2023.v.4i2
DOI:
10.47619/2713-2617.zm.2023.v.4i2;30-40
Language:
Unknown
Publisher:
Research Institute for Healthcare Organization and Medical Management
Publication Date:
2023
Permalink